Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | Zendy

John J. McNeil | Zendy; Mark Nelson | Zendy; Robyn L. Woods | Zendy; Jessica E. Lockery | Zendy; Rory Wolfe | Zendy; Christopher M. Reid | Zendy; Brenda Kirpach | Zendy; Raj C. Shah | Zendy; Diane G. Ives | Zendy; Elsdon Storey | Zendy; Joanne Ryan | Zendy; Andrew Tonkin | Zendy; Anne B. Newman | Zendy; Jeff D. Williamson | Zendy; Karen L. Margolis | Zendy; Michael E. Ernst | Zendy; Walter P. Abhayaratna | Zendy; Nigel Stocks | Zendy; Sharyn M. Fitzgerald | Zendy; Suzanne G. Orchard | Zendy; Ruth E. Trevaks | Zendy; Lawrence J. Beilin | Zendy; Geoffrey A. Donnan | Zendy; Peter Gibbs | Zendy; Colin I. Johnston | Zendy; Barbara Radziszewska | Zendy; Richard H. Grimm | Zendy; Anne M. Murray | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

Author(s) -

John J. McNeil,

Mark Nelson,

Robyn L. Woods,

Jessica E. Lockery,

Rory Wolfe,

Christopher M. Reid,

Brenda Kirpach,

Raj C. Shah,

Diane G. Ives,

Elsdon Storey,

Joanne Ryan,

Andrew Tonkin,

Anne B. Newman,

Jeff D. Williamson,

Karen L. Margolis,

Michael E. Ernst,

Walter P. Abhayaratna,

Nigel Stocks,

Sharyn M. Fitzgerald,

Suzanne G. Orchard,

Ruth E. Trevaks,

Lawrence J. Beilin,

Geoffrey A. Donnan,

Peter Gibbs,

Colin I. Johnston,

Barbara Radziszewska,

Richard H. Grimm,

Anne M. Murray

Publication year - 2018

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1803955

Subject(s) - aspirin , placebo , medicine , clinical endpoint , end point , cause of death , gerontology , randomized controlled trial , alternative medicine , disease , pathology , geometry , mathematics

In the primary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial, now published in the Journal, we report that the daily use of aspirin did not provide a benefit with regard to the primary end point of disability-free survival among older adults. A numerically higher rate of the secondary end point of death from any cause was observed with aspirin than with placebo.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research